Archive for Medication updates
NEWS ALERT: Concession Price – May 2024: 2nd Update
Members’ Service The DHSC has updated Concession prices for May (30th). Dispex members can login to our website to see the updates all together in one place, and in alphabetical...
New restrictions on puberty blockers
Source: Department of Health and Social Care 29.5.24 New regulations restrict the prescribing and supply of puberty-suppressing hormones to children and young people under 18. The Government has today introduced regulations to restrict the...
Class 4 Medicines Defect Information: Fresenius Kabi Limited, Sodium Chloride 0.9% Intravenous Infusion BP (Freeflex and Freeflex Plus), EL (24)A/17
Source: MHRA / Gov.uk 22.5.24 Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS. MDR...
NEW SOP: HRT Prescription Sorting P14
Dispex is pleased to provide its members with a SOP template library: All Templates MUST be personalised to individual practices. Scope HRT Prescription Sorting p14 This SOP applies specifically to...
NEWS FLASH: Drug Supply Update-18th May
Drug Supply Page Dispex provides primary care focused updates on drug supply issues. Data is taken from the SPS website on a weekly basis. 5 Resolved 2 discontinued Dispex members can...
Class 4 Medicines Defect Information: Doncaster Pharma Limited, Keppra 500mg film-coated tablets, EL(24)A/15
Source: MHRA / Gov.uk 15.5.24 Doncaster Pharma Limited have identified an error relating to the Braille printed on the cartons on various parallel imported packs which have been repackaged by...
Category A Pricing Changes
Category A products are generics which do not meet the threshold volumes to be included in Category M. From April 2024 and for the next 18 months, Category A prices,...
NEWS ALERT: Drug Supply Update-26th April
Drug Supply Page Dispex provides primary care focused updates on drug supply issues. Data is taken from the SPS website on a weekly basis. 3 new Unavailable 3 new Resolved Dispex...
Class 3 Medicines Recall: Neon Healthcare Ltd, Suprefact 1 mg/ml solution for injection
Source: MHRA /Gov.uk 23.4.24 (Cheplapharm – Canadian Livery), EL(24)A/14: Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure. MDR number MDR 191-04/24 Company...
Symbios ORIGIN® Posterior Stabilised Patient-Matched Total Knee Replacement Device
Source: MHRA/Gov.uk 23.4.24 Risk of Early Revision, DSI/2024/005 The MHRA was alerted by Beyond Compliance and the UK National Joint Registry (NJR) to a significantly higher revision rate observed with...
Out-of-pocket expense payment for unlicensed Cefuroxime 5% eye drops preservative free
From March 1st 2024, an additional fixed out-of-pocket expense payment of £50, will be automatically applied to NHS prescriptions for Cefuroxime 5% eye drops preservative free -a non-Drug Tariff special!...
Retrospective Top Up Payments for Concession Prices
The first list of Retrospective Top Up payments has been published in the April Drug Tariff. Every quarter, a retrospective top-up payment to the concessionary prices granted three quarters before...